Advance Search

Molecular subtypes of breast cancer: distribution and prognostic implications

Shwan Salam Marouf
Rizgary Teaching Hospital, Erbil, Iraq.
Keywords:
Copyright and Licensing:

Copyright (c) 2025 Shwan Salam Marouf (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Share:
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Background and objectives: Breast cancer is a heterogeneous disease complex with various molecular subtypes, each having unique features that significantly affect the disease's course, behavior, treatment response, and prognosis. This study aimed to investigate the incidence of different breast cancer molecular subtypes and to explore the associations between these subtypes and important prognostic characteristics, such as tumor grade and disease stage.

Methods: This study was a retrospective observational analysis of paper-based medical records of 187 female patients diagnosed with breast cancer and registered at the Oncology Center of Rizgary Teaching Hospital in Erbil City in 2021.

Results: Analyzing the records of the 187 confirmed breast cancer patients revealed that luminal-B was the most frequent breast cancer molecular subtype, followed by luminal-A, TNBC and HER2-enriched subtypes in order of decreasing frequency. Additionally, the study found a statistically significant association between breast cancer molecular subtypes and prognostic characteristics such as tumor grade (P <0.001), primary tumor size (P = 0.017) and axillary lymph node status (P = 0.002).

Conclusion: The findings revealed a significant association between different breast cancer molecular subtypes and key tumor characteristics such as tumor grade and TNM disease stage, potentially influencing therapeutic and prognostic outcomes.

PDF
PDF

Metrics

Metrics Loading ...

References

  1. Carvalho FM, Bacchi LM, Pincerato KM, Van de Rijn M, Bacchi CE. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. BMC Womens Health. 2014; 14:102. doi: 10.1186/1472-6874-14-102. PMID: 25174527; PMCID: PMC4153008.
  2. Acheampong T, Kehm RD, Terry MB, Argov EL, Tehranifar P. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016. JAMA Netw Open. 2020; 3(8):e2013226. doi: 10.1001/jamanetworkopen.2020.13226. PMID: 32804214; PMCID: PMC7431997.
  3. Emmanuelm. External appearance of a mastectomy specimen containing a very large invasive ductal carcinoma. 2009. Licensed under the Creative Commons Attribution 3.0 Unported license. (https://upload.wikimedia.org/wikipedia/commons/3/3f/BreastCancer.jpg)
  4. Hayman John. Human breast tissue, showing a stellate area of cancer 2 cm in diameter. The histology was that of a moderately well differentiated ductal carcinoma. 2007. Released into the public domain. (https://upload.wikimedia.org/wikipedia/commons/8/80/Breast_cancer.JPG)
  5. Zubair M, Wang S, Ali N. Advanced Approaches to Breast Cancer Classification and Diagnosis. Front Pharmacol. 2021; 11:632079. doi: 10.3389/fphar.2020.632079. PMID: 33716731; PMCID: PMC7952319.
  6. Masood S. Breast cancer subtypes: morphologic and biologic characterization. J Womens Health (Lond). 2016; 12(1):103-19. doi: 10.2217/whe.15.99. PMID: 26756229; PMCID: PMC5779568.
  7. Eliyatkın N, Yalçın E, Zengel B, Aktaş S, Vardar E. Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way. J Breast Health. 2015; 11(2):59-66. doi: 10.5152/tjbh.2015.1669. PMID: 28331693; PMCID: PMC5351488.
  8. Li Y, Wang S, Yang W, Liu H. Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study. Medicine (Baltimore) 2021; 100(27):e26619. doi: 10.1097/MD.0000000000026619. PMID: 34232220; PMCID: PMC8270584.
  9. Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, Gómez-Valles FO, Ramírez-Valdespino CA. Subtypes of Breast Cancer. In: Mayrovitz HN, editor. Breast Cancer [Internet]. Brisbane (AU): Exon Publications 2022. Chapter 3. PMID: 36122153.
  10. Zhao L, Lee VHF, Ng MK, Yan H, Bijlsma MF. Molecular subtyping of cancer: current status and moving toward clinical applications. Brief Bioinform. 2019; 20(2):572-84. doi: 10.1093/bib/bby026. PMID: 29659698.
  11. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ; Panel members. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011; 22(8):1736-47. doi: 10.1093/annonc/mdr304. PMID: 21709140; PMCID: PMC3144634.
  12. Vasconcelos I, Hussainzada A, Berger S, Fietze E, Linke J, Siedentopf F, et al. The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival. Breast. 2016; 29:181-5. doi: 10.1016/j.breast.2016.07.016. PMID: 27544822.
  13. Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marme F, et al. Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study. BMC Cancer. 2016; 16:734. doi: 10.1186/s12885-016-2766-3.
  14. Tran B, Bedard PL. Luminal-B breast cancer and novel therapeutic targets. Breast Cancer Res. 2011; 13. doi: 10.1186/bcr2904. Article 221.
  15. TečićVuger A, Šeparović R, Vazdar L, Pavlović M, Lepetić P, Šitić S, et al. Characteristics and prognosis of triple-negative breast cancer patients: a croatian single institution retrospective cohort study. Acta Clin Croat. 2020; 59(1):97-108. doi: 10.20471/acc.2020.59.01.12. PMID: 32724280; PMCID: PMC7382886.
  16. Tremont A, Lu J, Cole JT. Endocrine Therapy for Early Breast Cancer: Updated Review. Ochsner J. 2017; 17(4):405-11. PMID: 29230126; PMCID: PMC5718454.
  17. Kim J, Pareja F, Weigelt B, Reis-Filho JS. Prediction of Trastuzumab benefit in HER2-positive breast cancers: is it in the intrinsic subtype? J Natl Cancer Inst. 2017; 109(2). doi: 10.1093/jnci/djw218. Article djw218.
  18. Lebert JM, Lester R, Powell E, Seal M, McCarthy J. Advances in the systemic treatment of triple-negative breast cancer. Curr. Oncol. 2018; 25:S142–S150. doi: 10.3747/co.25.3954.
  19. AJCC Teichgraeber DC, Guirguis MS, Whitman GJ. Breast Cancer Staging: Updates in the AJCC Cancer Staging Manual, 8th Edition, and Current Challenges for Radiologists, From the AJR Special Series on Cancer Staging. AJR Am J Roentgenol. 2021; 217(2):278-90. doi: 10.2214/AJR.20.25223. PMID: 33594908.
  20. Shawarby M, Al-Tamimi D, Ahmed A. Molecular classification of breast cancer: an overview with emphasis on ethnic variations and future perspectives. Saudi J Med Sci. 2013;1:14–19.
  21. Mehdi I, Monem AA, Al Bahrani B, Ramadhan FA. Breast cancer molecular subtypes in Oman: correlation with age, histology, and stage distribution - analysis of 542 cases. Gulf J Oncolog. 2014; 1(15):38-48. PMID: 24610287.
  22. Ries LAG, Melbert D, Krapcho M. SEER Cancer Statistics Review 1975- 2021. National Cancer Institute, Bethesda, MD.
  23. Al-Thoubaity FK. Molecular classification of breast cancer: A retrospective cohort study. Ann Med Surg (Lond). 2019; 49:44-8. doi: 10.1016/j.amsu.2019.11.021. PMID: 31890196; PMCID: PMC6926136.
  24. Mohammed AA. The clinical behavior of different molecular subtypes of breast cancer. Cancer Treat Res Commun. 2021; 29:100469. doi: 10.1016/j.ctarc.2021.100469. PMID: 34624832.
  25. Joute Z, Debnath M, Pukhrambam G, Khuraijam S, Sarangthem B. Molecular subtypes of breast carcinoma and its relation with clinicopathological features: A single-center initial experience. J Med Soc. 2021; 35(3):103-7. DOI: 10.4103/jms.jms_5_22.
  26. Acheampong T, Kehm RD, Terry MB, Argov EL, Tehranifar P. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016. JAMA Netw Open. 2020; 3(8):e2013226. doi: 10.1001/jamanetworkopen.2020.13226. PMID: 32804214; PMCID: PMC7431997.
  27. Hjerkind KV, Johansson ALV, Trewin CB. Incidence of breast cancer subtypes in immigrant and non-immigrant women in Norway. Breast Cancer Res. 2022; 24:4. https://doi.org/10.1186/s13058-021-01498-5
  28. Fourati A, Boussen H, El May MV, Goucha A, Dabbabi B, Gamoudi A, et al. Descriptive analysis of molecular subtypes in Tunisian breast cancer. Asia Pac J Clin Oncol. 2014; 10(2):69-74. doi: 10.1111/ajco.12034. PMID: 23176549.
  29. Pal T, Bonner D, Cragun D, Monteiro AN, Phelan C, Servais L, et al. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer. 2015; 121(23):4173-80. doi: 10.1002/cncr.29645. PMID: 26287763; PMCID: PMC4666784.
  30. Domchek SM, Yao S, Chen F, Hu C, Hart SN, Goldgar DE, et al. Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women with Breast Cancer in the United States. JAMA Oncol. 2021; 7(7):1045-50. doi: 10.1001/jamaoncol.2021.1492. PMID: 34042955; PMCID: PMC8160931.
  31. Oluwagbemiga LA, Oluwole A, Kayode AA. Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review. SpringerPlus. 2012; 1(1):83. doi: 10.1186/2193-1801-1-83. Epub 2012
  32. Setyawati Y, Rahmawati Y, Widodo I, Ghozali A, Purnomosari D. The Association between Molecular Subtypes of Breast Cancer with Histological Grade and Lymph Node Metastases in Indonesian Woman. Asian Pac J Cancer Prev. 2018; 19(5):1263-8. doi: 10.22034/APJCP.2018.19.5.1263. PMID: 29801411; PMCID: PMC6031822.
  33. Isheden G, Grassmann F, Czene K, Humphreys K. Lymph node metastases in breast cancer: Investigating associations with tumor characteristics, molecular subtypes and polygenic risk score using a continuous growth model. Int J Cancer. 2021; 149(6):1348-57. doi: 10.1002/ijc.33704. PMID: 34097750.
  34. Li J, Chen Z, Su K, Zeng J. Clinicopathological classification and traditional prognostic indicators of breast cancer. Int J Clin Exp Pathol. 2015; 8(7):8500-5. PMID: 26339424; PMCID: PMC4555752.
How to Cite
Salam Marouf, S. . (2025). Molecular subtypes of breast cancer: distribution and prognostic implications. Zanco Journal of Medical Sciences (Zanco J Med Sci), 470–480. https://doi.org/10.15218/zjms.2025.050

Send mail to Author

Send Cancel